Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies

Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies

Thumbnail Image
Download
Name

1-s2.0-S2211124719317528-main.pdf

Description
Published version
Size

4.57 MB

Format

Adobe PDF

Checksum (MD5)

4bd8a9d6e71d9f730e1ec9f9dd91900e

sword-2020-09-21T14:15:47.original.xml (130 B)
Original SWORD entry document
Author(s)
Martin-Gayo, Enrique
•
Gao, Ce
•
Chen, Hsiao Rong
•
Ouyang, Zhengyu
•
Kim, Dhohyung
•
Kolb, Kellie Elizabeth
•
Shalek, Alexander K
•
Walker, Bruce D.
•
Lichterfeld, Mathias
•
Yu, Xu G.
Date Issued
January 2020
Journal
Cell Reports
Publisher
Elsevier BV
Citation
Martin-Gayo, Enrique et al. "Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies." Cell Reports 30, 4 (January 2020): P984-996.e4 © 2019 The Author(s)
Version
Final published version
Abstract
The induction of broadly neutralizing antibodies (bnAbs) is highly desired for an effective vaccine against HIV-1. Typically, bnAbs develop in patients with high viremia, but they can also evolve in some untreated HIV-1 controllers with low viral loads. Here, we identify a subgroup of neutralizer-controllers characterized by myeloid DCs (mDCs) with a distinct inflammatory signature and a superior ability to prime T follicular helper (Tfh)-like cells in an STAT4-dependent fashion. This distinct immune profile is associated with a higher frequency of Tfh-like cells in peripheral blood (pTfh) and an enrichment for Tfh-defining genes in circulating CD4+ T cells. Correspondingly, monocytes from this neutralizer controller subgroup upregulate genes encoding for chemotaxis and inflammation, and they secrete high levels of IL-12 in response to TLR stimulation. Our results suggest the existence of multi-compartment immune networks between mDCs, Tfh, and monocytes that may facilitate the development of bnAbs in a subgroup of HIV-1 controllers.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution 4.0 International license
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/127670
DOI of Published Version
https://doi.org/10.1016/j.celrep.2019.12.087
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.